0001203311-23-000014.txt : 20230215
0001203311-23-000014.hdr.sgml : 20230215
20230215183318
ACCESSION NUMBER: 0001203311-23-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230213
FILED AS OF DATE: 20230215
DATE AS OF CHANGE: 20230215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRYSKA DAVID W
CENTRAL INDEX KEY: 0001202335
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 23636682
MAIL ADDRESS:
STREET 1: 749 N MARY AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2023-02-13
0
0001060736
Seagen Inc.
SGEN
0001202335
GRYSKA DAVID W
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
0
0
0
Common Stock
2023-02-13
4
M
0
8750
36.7
A
49003
D
Non-Qualified Stock Option (right to buy)
36.7
2023-02-13
4
M
0
8750
0.0
D
2023-05-17
Common Stock
8750
0
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Options were fully vested on 5/16/14.
By: /s/ Jennifer Prosba For: David W. Gryska
2023-02-15